112 related articles for article (PubMed ID: 38508144)
21. Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Gartlgruber M; Sharma AK; Quintero A; Dreidax D; Jansky S; Park YG; Kreth S; Meder J; Doncevic D; Saary P; Toprak UH; Ishaque N; Afanasyeva E; Wecht E; Koster J; Versteeg R; Grünewald TGP; Jones DTW; Pfister SM; Henrich KO; van Nes J; Herrmann C; Westermann F
Nat Cancer; 2021 Jan; 2(1):114-128. PubMed ID: 35121888
[TBL] [Abstract][Full Text] [Related]
22. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.
D'Oto A; Fang J; Jin H; Xu B; Singh S; Mullasseril A; Jones V; Abu-Zaid A; von Buttlar X; Cooke B; Hu D; Shohet J; Murphy AJ; Davidoff AM; Yang J
Nat Commun; 2021 Dec; 12(1):7204. PubMed ID: 34893606
[TBL] [Abstract][Full Text] [Related]
23. ATR inhibition enables complete tumour regression in ALK-driven NB mouse models.
Szydzik J; Lind DE; Arefin B; Kurhe Y; Umapathy G; Siaw JT; Claeys A; Gabre JL; Van den Eynden J; Hallberg B; Palmer RH
Nat Commun; 2021 Nov; 12(1):6813. PubMed ID: 34819497
[TBL] [Abstract][Full Text] [Related]
24. Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
Singh S; Quarni W; Goralski M; Wan S; Jin H; Van de Velde LA; Fang J; Wu Q; Abu-Zaid A; Wang T; Singh R; Craft D; Fan Y; Confer T; Johnson M; Akers WJ; Wang R; Murray PJ; Thomas PG; Nijhawan D; Davidoff AM; Yang J
Sci Adv; 2021 Nov; 7(47):eabj5405. PubMed ID: 34788094
[TBL] [Abstract][Full Text] [Related]
25. EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma.
Durbin AD; Wang T; Wimalasena VK; Zimmerman MW; Li D; Dharia NV; Mariani L; Shendy NAM; Nance S; Patel AG; Shao Y; Mundada M; Maxham L; Park PMC; Sigua LH; Morita K; Conway AS; Robichaud AL; Perez-Atayde AR; Bikowitz MJ; Quinn TR; Wiest O; Easton J; Schönbrunn E; Bulyk ML; Abraham BJ; Stegmaier K; Look AT; Qi J
Cancer Discov; 2022 Mar; 12(3):730-751. PubMed ID: 34772733
[TBL] [Abstract][Full Text] [Related]
26. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.
Van de Velde LA; Allen EK; Crawford JC; Wilson TL; Guy CS; Russier M; Zeitler L; Bahrami A; Finkelstein D; Pelletier S; Schultz-Cherry S; Thomas PG; Murray PJ
Cancer Res; 2021 Oct; 81(19):5047-5059. PubMed ID: 34301764
[TBL] [Abstract][Full Text] [Related]
27. Combined inhibition of Aurora-A and ATR kinase results in regression of
Roeschert I; Poon E; Henssen AG; Garcia HD; Gatti M; Giansanti C; Jamin Y; Ade CP; Gallant P; Schülein-Völk C; Beli P; Richards M; Rosenfeldt M; Altmeyer M; Anderson J; Eggert A; Dobbelstein M; Bayliss R; Chesler L; Büchel G; Eilers M
Nat Cancer; 2021 Mar; 2(3):312-326. PubMed ID: 33768209
[TBL] [Abstract][Full Text] [Related]
28. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.
Jansky S; Sharma AK; Körber V; Quintero A; Toprak UH; Wecht EM; Gartlgruber M; Greco A; Chomsky E; Grünewald TGP; Henrich KO; Tanay A; Herrmann C; Höfer T; Westermann F
Nat Genet; 2021 May; 53(5):683-693. PubMed ID: 33767450
[TBL] [Abstract][Full Text] [Related]
29. A first-generation pediatric cancer dependency map.
Dharia NV; Kugener G; Guenther LM; Malone CF; Durbin AD; Hong AL; Howard TP; Bandopadhayay P; Wechsler CS; Fung I; Warren AC; Dempster JM; Krill-Burger JM; Paolella BR; Moh P; Jha N; Tang A; Montgomery P; Boehm JS; Hahn WC; Roberts CWM; McFarland JM; Tsherniak A; Golub TR; Vazquez F; Stegmaier K
Nat Genet; 2021 Apr; 53(4):529-538. PubMed ID: 33753930
[TBL] [Abstract][Full Text] [Related]
30. Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress.
Zhang W; Liu W; Jia L; Chen D; Chang I; Lake M; Bentolila LA; Wang CY
Mol Cell; 2021 May; 81(10):2148-2165.e9. PubMed ID: 33743195
[TBL] [Abstract][Full Text] [Related]
31.
Floros KV; Cai J; Jacob S; Kurupi R; Fairchild CK; Shende M; Coon CM; Powell KM; Belvin BR; Hu B; Puchalapalli M; Ramamoorthy S; Swift K; Lewis JP; Dozmorov MG; Glod J; Koblinski JE; Boikos SA; Faber AC
Cancer Res; 2021 Apr; 81(7):1896-1908. PubMed ID: 33483374
[No Abstract] [Full Text] [Related]
32. LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors.
Tao T; Shi H; Mariani L; Abraham BJ; Durbin AD; Zimmerman MW; Powers JT; Missios P; Ross KN; Perez-Atayde AR; Bulyk ML; Young RA; Daley GQ; Look AT
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16516-16526. PubMed ID: 32601179
[TBL] [Abstract][Full Text] [Related]
33. Oncometabolites suppress DNA repair by disrupting local chromatin signalling.
Sulkowski PL; Oeck S; Dow J; Economos NG; Mirfakhraie L; Liu Y; Noronha K; Bao X; Li J; Shuch BM; King MC; Bindra RS; Glazer PM
Nature; 2020 Jun; 582(7813):586-591. PubMed ID: 32494005
[TBL] [Abstract][Full Text] [Related]
34. Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis.
Wang J; Li Y; Wang P; Han G; Zhang T; Chang J; Yin R; Shan Y; Wen J; Xie X; Feng M; Wang Q; Hu J; Cheng Y; Zhang T; Li Y; Gao Z; Guo C; Wang J; Liang J; Cui M; Gao K; Chai J; Liu W; Cheng H; Li L; Zhou F; Liu L; Luo Y; Li S; Zhang H
Cell Stem Cell; 2020 Jul; 27(1):81-97.e8. PubMed ID: 32402251
[TBL] [Abstract][Full Text] [Related]
35. Epigenomic profiling of neuroblastoma cell lines.
Upton K; Modi A; Patel K; Kendsersky NM; Conkrite KL; Sussman RT; Way GP; Adams RN; Sacks GI; Fortina P; Diskin SJ; Maris JM; Rokita JL
Sci Data; 2020 Apr; 7(1):116. PubMed ID: 32286315
[TBL] [Abstract][Full Text] [Related]
36. MYCN amplification and ATRX mutations are incompatible in neuroblastoma.
Zeineldin M; Federico S; Chen X; Fan Y; Xu B; Stewart E; Zhou X; Jeon J; Griffiths L; Nguyen R; Norrie J; Easton J; Mulder H; Yergeau D; Liu Y; Wu J; Van Ryn C; Naranjo A; Hogarty MD; Kamiński MM; Valentine M; Pruett-Miller SM; Pappo A; Zhang J; Clay MR; Bahrami A; Vogel P; Lee S; Shelat A; Sarthy JF; Meers MP; George RE; Mardis ER; Wilson RK; Henikoff S; Downing JR; Dyer MA
Nat Commun; 2020 Feb; 11(1):913. PubMed ID: 32060267
[TBL] [Abstract][Full Text] [Related]
37. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
38. Histone Lysine Methylation Dynamics Control
Clarke TL; Tang R; Chakraborty D; Van Rechem C; Ji F; Mishra S; Ma A; Kaniskan HÜ; Jin J; Lawrence MS; Sadreyev RI; Whetstine JR
Cancer Discov; 2020 Feb; 10(2):306-325. PubMed ID: 31776131
[TBL] [Abstract][Full Text] [Related]
39. Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation.
Duan L; Chen Z; Lu J; Liang Y; Wang M; Roggero CM; Zhang QJ; Gao J; Fang Y; Cao J; Lu J; Zhao H; Dang A; Pong RC; Hernandez E; Chang CM; Hoang DT; Ahn JM; Xiao G; Wang RT; Yu KJ; Kapur P; Rizo J; Hsieh JT; Luo J; Liu ZP
Nucleic Acids Res; 2019 Dec; 47(22):11623-11636. PubMed ID: 31647098
[TBL] [Abstract][Full Text] [Related]
40. ChIPseqSpikeInFree: a ChIP-seq normalization approach to reveal global changes in histone modifications without spike-in.
Jin H; Kasper LH; Larson JD; Wu G; Baker SJ; Zhang J; Fan Y
Bioinformatics; 2020 Feb; 36(4):1270-1272. PubMed ID: 31566663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
